Skip to main content
Clinical Trials/NCT06574256
NCT06574256
Completed
Not Applicable

Investigation of the Effect of Online Nursing Education Given to Patients Diagnosed With Gynecological Cancer and Receiving Chemotherapy on Symptoms, Quality of Life and Patient Satisfaction

Celal Bayar University1 site in 1 country90 target enrollmentDecember 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gynecological Cancer
Sponsor
Celal Bayar University
Enrollment
90
Locations
1
Primary Endpoint
EORT QLQ-C30
Status
Completed
Last Updated
last year

Overview

Brief Summary

The aim of the study was to examine the effect of online nursing education given to women diagnosed with gynecological cancer and receiving chemotherapy. It was conducted as a randomized controlled experimental study. The study examined the effect of online nursing education given to patients in the intervention group diagnosed with gynecological cancer and receiving chemotherapy on symptoms, quality of life and patient satisfaction. The control group received routine nursing care.

Detailed Description

This study examined the effect of online nursing education given to women diagnosed with gynecological cancer and receiving chemotherapy. This randomized controlled experimental study was conducted in a public hospital in Balıkesir province between December 1, 2021 and June 1, 2024. The study sample consisted of 90 women (intervention=45, control=45). Online nursing education was given to women in the intervention group receiving chemotherapy. Patients in the control group received routine nursing care. The study used the women's descriptive characteristics questionnaire, disease and treatment questionnaire, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, Nightingale Symptom Assessment Scale, nurse follow-up form and patient satisfaction questionnaire. Data were collected during three chemotherapy cycles in four phases.

Registry
clinicaltrials.gov
Start Date
December 1, 2021
End Date
June 1, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

yşegül Beyazpınar KAVAKLIOĞLU

principal investigator

Celal Bayar University

Eligibility Criteria

Inclusion Criteria

  • Patients who are diagnosed with gynecological cancer and who have started chemotherapy treatment for the first time in the hospital,
  • having gynecological cancer
  • receiving chemotherapy
  • Speak Turkish, have no communication problems,
  • Accept voluntarily to participate in the study,
  • Patients who are 18 years of age or older

Exclusion Criteria

  • Illiterate Patients who do not have a smart phone or computer Patients who receive radiotherapy together with chemotherapy Patients who do not know they have been diagnosed with cancer

Outcomes

Primary Outcomes

EORT QLQ-C30

Time Frame: three monhts

EORT QLQ-C30: It consists of three main dimensions and 30 questions, namely general well-being, functional difficulties and symptom control.

Nightingale symptom assessment scale

Time Frame: three monhts

Nightingale symptom assessment scale: This scale, consisting of 38 items, has three sub-dimensions, namely physical, social and psychological well-being.

Secondary Outcomes

  • Nightingale Symptom Assessment Scale(three months)
  • European Organization for Research and Treatment of Cancer Quality of Life Questionnaire,(three monhts)
  • patient satisfaction(one months)

Study Sites (1)

Loading locations...

Similar Trials